View Post

Hep B Vaccination Protects People with HIV

In COVID-19, Latest News by Precision Vaccinations

Recent peer-reviewed research out of Cincinnati showed that an entire course of a hepatitis B vaccine provides substantial protection for people living with HIV.
The University of Cincinnati (UC) research published on October 20, 2022, shows that three doses of a hepatitis B vaccine protect people with HIV who had not been vaccinated against or exposed to the hepatitis B virus (HBV).

View Post

Pneumonia Outpaces COVID-19 and Influenza Fatalities

In COVID-19, Latest News by Precision Vaccinations

As World Pneumonia Day approaches on November 12th, the ongoing effort to reduce fatalities from infectious diseases has never been more urgent.
Pneumonia is an infection of the lungs that needlessly affects millions worldwide each year. Most of the people affected by pneumonia in the U.S. are adults.
Previous U.S. CDC data indicates 47,000 people died from pneumonia in the U.S. in 2020.
And that negative trend continues today.

View Post

An Old Vaccine Resolves Tuberculosis Concerns

In COVID-19, Latest News by Precision Vaccinations

In the midst of stalling progress, there are some successes to report on the eradication of tuberculosis (TB), announced the World Health Organization (WHO).
While the world focused on the pandemic, about 26 million people were treated for TB between 2018 and 2021.
Of the 30 high TB-burden countries with the highest treatment coverage levels in 2021 included Bangladesh, Brazil, China, Uganda, and Zambia.
This data falls short of the 40 million targets previously set at the UN High-Level Meeting on TB.

View Post

Severe Monkeypox Impacts People with HIV

In COVID-19, Latest News by Precision Vaccinations

During previous monkeypox outbreaks, severe disease manifestations and poor outcomes have been reported among persons with HIV infection, particularly those with AIDS.
A U.S. CDC  Morbidity and Mortality Weekly Report (MMWR) issued on October 26, 2022, summarizes findings from CDC clinical consultations provided for 57 adult patients who were hospitalized with severe manifestations of monkeypox from August 10–October 10, 2022.